Furthermore, EPO transgenic mice display significantly lower levels of blood glucose, insulin and HA1C, and are resistant to high fat diet (HFD)-induced glucose intolerance and insulin resistance [6], [7]. The gene discussed is INS; the disease is Glucose intolerance.